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1. Introduction 
All organisms live in the environment that contains oxygen which is vital for all aerobic 
organisms, and reactive oxygen species (ROS) which are formed in cells as a consequence of 
aerobic metabolism. Moreover mitochondrial respiration (a base of energetic production in 
all eukaryotic organisms) is associated with an inevitable electron leak, resulting in a non-
stop production of reactive oxygen species, such as superoxide anion radical, hydrogen 
peroxide and hydrogen radical. Universal nature of reactive oxygen species is underlined 
by the presence of one enzyme - superoxide dismutase. This enzyme occurs in all aerobic 
organisms and it is responsible for dismutation of superoxide anions into oxygen and 
hydrogen peroxide. Genes involved in detoxification of reactive oxygen species are highly 
conserved among eukaryotes and their deficiency could be limit of several diseases and life 
span. Oxidative stress is a unique pathophysiological condition resulting from the 
disrupted balance between oxidants and antioxidants. Increased level of reactive oxygen 
species may cause oxidative damage of all biomolecules: nucleic acids, proteins, lipids, 
saccharides. A progressive grow of oxidative damage is the result of increasing production 
of reactive oxygen species or an insufficient antioxidant defence system and this damage 
may contribute to the origin and development of several diseases including bronchial 
asthma, but on the other hand oxidative damage can be the consequence of them as well 
(fig. 1). 
The lungs have the highest exposure to atmospheric oxygen. This organ is vulnerable to 
oxidative damage by oxygen and pollutants (tobacco smoke, ozone, silicon, asbestos, oxides 
of nitrogen and sulphur) because of its location, anatomy and function. The large 
endothelial surface (100 m2) makes the lungs a major target site for circulating oxidants and 
xenobiotics. Bronchial asthma is the most frequent chronic respiratory disease in children. It 
is characterized by on-going airway inflammation commonly associated with airway 
remodelling. Oxidative damage is not only result of non-controlled airway inflammation 
but it can be a significant factor in the provoking of asthma exacerbations and in the 
maintenance of asthmatic symptoms, and may play one of the essential roles in the 
development and persistence of bronchial asthma. Oxidative damage may represent a 
potential target of the treatment of bronchial asthma. 
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Endogenous production of ROS occurs in vivo as by-products of enzymatic redox chemistry 
and traces of the iron and other metals catalyse oxidative reaction in vivo. Production of 
highly reactive oxygen species causes progressive, causal damage of nuclear DNA, 
mitochondrial DNA, RNA, enzymes, other proteins as well as unsaturated fatty acids and 
phospholipids. These kinds of damage may lead to a cell damage, changed cell function, 
and finally to a cell death. 
 
Fig. 1. Reactive oxygen species in the development of disease. As a consequence of 
disturbed equilibrium between reactive oxygen species (ROS) and antioxidants (AO) on the 
side of ROS, oxidative stress is increased. This causes increased oxidative damage of 
biomolecules, its accumulation, and the development of several diseases. 
2. Origin of reactive oxygen species 
Higher eukaryotic organisms cannot exist without oxygen. Molecular oxygen is essential for 
energy production in its diatomic basic state (3∑g-O2 or O2). During a lot of primary 
intracellular reactions in which oxygen is necessary, reactive oxygen species are produced. 
Oxygen and reactive oxygen species have destructive properties that can explain wide 
palette of medical states which become during origin and duration of many diseases. Single 
oxygen is not extremely reactive. Oxygen has two unpaired electrons which have parallel 
spin quantum number and they are localized in different molecular orbital and therefore 
oxygen molecule is quantified as diradical. If oxygen wants to accept two electrons both of 
them could have antiparallel spin. This criterion is executed very rarely in a typical electron 
pair. Therefore oxygen accept electrons for one in time and in vivo it is typical two- or four-
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electron reduction of oxygen using coordinating, serial enzymatic catalysed one-electron 
reductions (Beckman & Ames, 1998). 
Reactive oxygen species are created in the organism under normal physiological conditions 
after controlled stimulation like by-product of some biological processes. There are several 
sources of exogenous oxidant production as well (fig. 2). Four from the endogenous sources 
(mitochondria, phagocytes, peroxisomes, and cytochrome P450 enzymes) are responsible for 
origin of the majority of oxidants produced by cells (Ames et al. 1993). 
 
Fig. 2. Endogenous and exogenous sources of reactive oxygen species. 
The main endogenous source of reactive oxygen species are mitochondria which produce 
reactive oxygen species continuously. The main mitochondrial function is energy 
production. In normal aerobic respiration mitochondria utilize oxygen that is reduced by 
serial steps whereby is produced water (H2O). Mitochondria are the major producer of 
reactive oxygen species via incomplete reduction of oxygen by electrons leaked out of the 
respiratory chain in the animal and human cells. It has been demonstrated that NADH-
coenzyme Q oxidoreductase (Complex I) and ubiquinol-cytochrome c reductase (Complex 
III) of the respiratory chain are the major sites that generate reactive oxygen species in 
animal mitochondria. Mitochondrial oxidative damage can lead to the release of greater 
amount of reactive oxygen species and cause increased oxidative damage of mitochondrial, 
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cytoplasmic and nuclear components what subsequently may lead to dysfunctional 
mitochondria. Damage of mitochondrial electron transport may be an important factor in 
the pathogenesis of many diseases. 
Phagocytig cells are another important endogenous source of oxidants. The main function 
of phagocytosis is the defence of host organisms against pathogens, conditionally 
pathogenic micro-organisms and foreign as well as body own particles bigger than 0.1 µm. 
Neutrophils and another phagocytes attack pathogens by mixture of reactive oxygen 
species: singlet oxygen (O2-), nitric oxide (NO), hydrogen peroxide (H2O2), hypochlorous 
acid (HClO) (Pollack & Leeuwenburgh, 1999). Chronic virus, bacterial or parasite infection 
results in chronic increased phagocyting activity and finally chronic inflammation, which is 
a main risk factor for development of several diseases (Ames et al., 1993), and raising 
oxidative damage. 
Peroxisomes are organelles from the microbody family and are present in almost all 
eukaryotic cells. They participate in the ǃ-oxidation of fatty acids and in the metabolism of 
many others metabolites. Certain enzymes within peroxisome, by using molecular oxygen, 
remove hydrogen atoms from specific organic substrates, in an oxidative reaction, 
producing hydrogen peroxide. Hydrogen peroxide is degraded by catalase, another enzyme 
in peroxisome (Beckman & Ames, 1998). Peroxisomes contain also xanthine oxidase which 
produces singlet oxygen and hydrogen peroxide. 
Microsomal cytochrome P450 enzymes are a very large and diverse superfamily of 
hemoproteins identified from all lineages of life including humans, mammals, birds, fish, 
plants, bacteria. They form one of the primary defence system against xenobiotic compounds 
usually plant origin. Human cytochrome P450 enzymes are primarily membrane-associated 
proteins, located in the inner mitochondrial membrane or in the endoplasmic reticulum of 
cells. They modify thousands of endogenous and exogenous compounds by univalent 
oxidation or reduction. Induction of these enzymes protects from acute oxidative effects of 
foreign compounds or chemicals but also results in production of oxidants. 
The main cellular sources of ROS in the lung include neutrophils, eosinophils, alveolar 
macrophages, alveolar epithelial cells, bronchial epithelial cells and endothelial cells 
(Kinnula et al., 1992, 1995). 
2.1 Types of reactive oxygen species 
Reactive oxygen species are chemical units which are divided into two groups: free radicals 
and non-radical compounds (fig. 3). Free radical or radical is an atom, molecule or 
compound which has, contrary to non-radical atoms, one or more unpaired electrons. 
One of the basic properties of reactive oxygen species is their extreme reactivity. Reactive 
oxygen species oxidize molecules and therefore they are named oxidant. They can also act 
as a reducing factor, can be electron neutral but also can have positive or negative charge. 
Radicals are predominantly high reactive and they initiate complex line of consequential 
reactions by which other new reactive oxygen species are formed. Results of these series 
reactions are chemical modification of amino acids, peptides, proteins, nucleotides, nucleic 
acids, fatty acids, lipids and saccharides. Structural changes of biological molecules, which 
are situated in the proximity of their reactive species cause change of their biological 
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function. Reactive oxygen species participate on regulation of several physiological 
functions of cells and organisms such as cell signalling, neurotransmission and regulation of 
neurotransmitters release, gene expression, metabolism, cell proliferation and grow cells, 
immunity answer, and control of contraction and relaxation of smooth muscles, 
respiration, cell death (Chan, 2001; Halliwell and Gutteridge, 1999; Hanafy et al., 2001; 
Kroncke, 2001). Control of signal (Chan, 2001; Kroncke, 2001) and metabolic pathways 
(Halliwell and Gutteridge, 1999; Hanafy et al., 2001) through reactive oxygen species has 
meaning not only during physiological state of organism but supposes that during 
definite conditions deregulation of reactive oxygen species production participate on 
various kinds of diseases. 
 
Fig. 3. Examples of reactive oxygen species. 
2.2 Antioxidant defense 
Reactive oxygen species are necessary for human life. Many vital events are mediated by 
radical reactions in organism. Reactive oxygen species serve as signal molecules in low 
concentrations but if they are produced in oversize amount evoke harmful, destructive 
effects (Dhalla et al., 2000). Toxicity connected with inadequate production of these species 
is prevented by antioxidant defence systems that provides healthy cell environment. Cells 
possess enzymatic and non-enzymatic defence systems (dietary antioxidants, extracellular 
compounds that have antioxidant activity) (fig. 4) (Bergendi et al., 1999; Pollack & 
Leeuwenburgh, 1999). 
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Superoxid dismutase (SOD, EC 1.15.1.1) is universal enzymatic antioxidant. This enzyme is 
extremely efficient and catalyses the neutralization of superoxide anion to oxygen and 
hydrogen peroxide. There are three major families of superoxide dismutase, depending on 
the metal cofactor: Cu/Zn (which binds both copper and zinc), Fe and Mn types (which 
bind either iron or manganese), and the Ni type (which binds nickel). In humans three form 
of SOD are present: cytoplasmic Cu/Zn-SOD (SOD1), mitochondrial Mn-SOD (SOD2), and 
extracellular Cu/Zn-SOD (ECSOD, SOD3). 
 
Fig. 4. Antioxidant defence systems in organism. O2-, superoxide anion; GSH, glutathione; 
GSSG, glutathione disulfide; ROOH, alkyl hydroperoxide. 
Catalase (CAT, EC 1.11.1.6) is a common antioxidant enzyme responsible for controlling 
hydrogen peroxide concentrations in cells. It is ubiquitous to most aerobic cells and is 
situated in the lungs as well (macrophages, fibroblasts, and pneumocytes) (Kinnula et al., 
1995). Catalase as an intracellular antioxidant enzyme catalyzes the decomposition of two 
molecules of hydrogen peroxide into one molecule of oxygen and two of water and its 
activity is genetically determined. 
Glutathione peroxidases (GPXs, EC 1.11.1.9) are family of enzymes ubiquitously 
distributed which have peroxidase activity whose a main biological role is to protect the 
organism from oxidative damage. Glutathione peroxidases reduce hydrogen peroxide to 
water and reduced glutathione and lipid hydroperoxides to their corresponding alcohols, 
water and reduced glutathione. Four type of GPXs have been identified: cellular GPX, 
gastrointestinal GPX, etracellular GPX, and phospholipid hydroperoxide GPX (Tappel, 
1984). 
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Glutathione reductase (GR, EC 1.8.1.7) participates on maintenance of intracellular 
concentration of glutathione. 
Other an essential part of defence mechanism is a super-family of enzymes called 
glutathione transferases (GSTs, EC 2.5.1.18). These enzymes are involved in the cellular 
detoxification of various electrophilic xenobiotic substances such as chemical carcinogens, 
environmental pollutants, and antitumor agents. Glutathione transferases inactivate 
endogenous ǂ,ǃ-unsaturated aldehydes, quinone, epoxides, and hydroperoxides formed as 
secondary metabolites during oxidative damage. GSTs may reduce reactive oxygen species 
to less reactive metabolites and protect organism against consequences of lipid peroxidation. 
Glutathione transferases are of interest to researchers because they provide targets for 
antiasthmatic and antitumor drug therapies (Ruscoe et al., 2001). 
Glutathione (GSH, Ǆ,L-Glutamyl-L-cysteinylglycine) is an important antioxidant which 
reduces organic hyperoxides and protect organs from lipid peroxidation. 
Heme oxygenase (heat shock protein 32, HO; EC 1.14.99.3) plays an important role in 
organism defence to oxidative stress (Paredi et al., 1999) and inflammation (Otterbien & 
Choi, 2000). There are known tree isoforms of HO: HO-1, HO-2, and HO-3. HO-1 is 
activated by a lots of inflammatory mediators, reactive oxygen species and by another 
stimuli (proinflammatory cytokines: interleukin-1ǃ, interleukin-6, interferon-Ǆ, tumor 
necrosis factor-ǂ, bacterial toxins; airway viral infection; heme; hemin; reactive oxygen 
species: superoxide, peroxynitrite, hydrogen peroxide and reactive nitrogen species) (Nath 
et al., 2001; Sardana et al., 1981). HO-1 is expresses mainly in epithelial cells and endothelial 
cells of air system (Paredi et al., 1999). 
Although cells possess complex net of antioxidant defence, the defence is not completely 
effective. Small fractions of oxidants escape from elimination and cause molecular damage. 
Some of these damages are irreversible therefore they are accumulated in time and they 
make base of functional decline. At specific conditions production of reactive oxygen species 
is increased and thereby balance between reactive oxygen species and defence systems is 
disrupted. In consequence, imbalance between oxidants and antioxidants in favour of 
oxidants and their harmful effects, oxidative damage is increased. Oxidative damage of 
biomolecules is a major contributor factor to many diseases such as cardiovascular and 
neurological diseases, lung diseases, ischemia-reperfusion injury, cancer and cataracts 
(Ames at al., 1993) and to physiological processes such as ageing and protein turnover 
(Fukagawa, 1999; Stadtman, 1993). 
3. Bronchial asthma 
Bronchial asthma (BA) is a lung disorder characterized by inflammation and airway 
hyperresponsiveness. The causes and pathogenic mechanisms of BA are poorly understood, 
and available treatments do not reverse and stop the disease process. Bronchial asthma has a 
significant global impact, affecting approximately 300 million individuals worldwide. The 
prevalence of bronchial asthma increases significantly during past years, especially in 
children. Asthma has become more common in both children and adults around the world 
in recent decades. The increase in the prevalence of asthma has been associated with an 
increase in atopic sensitization, and is paralleled by similar increases in other allergic 
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disorders such as eczema and rhinitis. Asthma is a complex and heterogeneous chronic 
inflammatory disease of airways that involves the activation of many inflammatory and 
structural cells, all of which release inflammatory mediators that result in the typical 
pathophysiological changes in asthma (Barnes at al., 1998). Bronchial asthma is 
characterized by recurrent episodes of airway obstruction that resolve spontaneously or as a 
result of treatment, which occurs in individuals who may periodically have normal airway 
function. The airway mucosal inflammatory response in asthma is characterized by 
increased vascular permeability with oedema of airway walls, mucus hypersecretion with 
small airway plugging and infiltration by inflammatory cells, typically eosinophils. 
Prominent symptoms include wheezing, breathlessness, chest tightness, and cough, 
particularly at night and/or early in the morning. 
Asthma has been recognized as a disease since the earliest times; Hippocrates used the 
term “ǂǅθμǂ”. The pathogenesis of BA is complicated and at present poorly understood. 
Asthma is a disorder involving all bronchial structures and depends on a complex 
interaction between the respiratory tract and inflammatory cells, mediators and adhesion 
molecules. Release of mediators primes both activation and migration of inflammatory 
cells that cause various degrees of airway obstruction, alternations in the mucociliary 
system and hyperreactivity o the bronchial smooth muscles. The cells infiltrating the 
bronchial mucosa in patients with asthma produce also reactive oxygen species 
(Andreadis at al., 2003). Oxidative damage plays an important role in the development of 
bronchial asthma. Increase production of reactive oxygen species leads to mutagenic 
alternations resulting in many pathological processes and can be implicated in 
pathogenesis of asthma. 
 
Fig. 5. Participation of oxidative damage in the bronchial asthma origin. 
Protein oxidation, DNA modification and lipid peroxidation, all of these oxidative changes 
can be cumulated in airway and may participate to bronchial asthma persistence and lead to 
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further release of mediators from epithelium resulting in further increase of oxidative 
damage which can again participate in asthma pathogenesis (fig. 5). Oxidative damage 
represents dynamic balance between a degree of oxidative damage and a degree of repair of 
this damage. Changes are not happened only in consequence of oxidative damage of 
biomolecules but also in consequence of damage of repair mechanisms. 
Direct evidences of a causal role of reactive oxygen species in asthma are limited. Reactive 
oxygen species can influence airway cells and initiate lipid peroxidation, protein oxidation, 
DNA modification, enhancing release of arachidonic acid from cell membranes, contracting 
airway smooth muscle, increasing vascular permeability, increasing airway reactivity and 
airway secretion, as well as the synthesis and release of chemoattractants, inducing the 
release of tachykinins and neurokinins, decreasing cholinesterase and neutral 
endopeptidase activities, and impairing the responsiveness of ǃ-adrenergic receptors 
(Barnes, 1994; Barnes et al., 1998; Rahman & MacNee, 2002). Increased oxidative damage can 
contribute to the origin and development of respiratory disease including bronchial asthma. 
3.1 Oxidative damage in bronchial asthma 
Oxidative damage has myriad effects and can negatively influence metabolic pathways 
including amplifying the inflammatory process. Changes in levels of oxidants, antioxidants 
and markers of oxidative damage can be determined in bronchoalveolar lavage fluid (BAL), 
plasma, serum, tissue and as well as in exhaled breath condensate. Our measurements are 
still limited by low concentration of reactive oxygen species, their extreme reactivity and 
short lifetime and therefore a determination of biomarkers which can reflect existence of 
reactive oxygen species predominates over direct evidences of increased origin of reactive 
oxygen species. 
The ability to collect and analyse exhaled condensate has allowed the direct assessment of 
reactive oxygen species in allergic respiratory diseases. Higher concentration of hydrogen 
peroxide (Emelyanov et al., 2001; Horvath et al., 1998), superoxide anion radical (Jarjour & 
Calhoun, 1994; Sedgwick et al., 1990; Teramoto et al., 1996), nitric oxide (Ashutosh, 2000; 
Banovcin et al., 2009) was observed in asthmatic patients. Data about normal physiological 
value of ROS and oxidative damage biomarkers of DNA, proteins and lipids are missing or 
very rare in adults or in children population and therefore an implication of relevant 
conclusion can be uncertain. 
3.1.1 Protein oxidative damage 
A prominent marker of oxidative damage is oxidative damage of proteins. Endogenous 
proteins are very sensitive to modification by reactive oxygen species. Oxidized proteins can 
loss their biological function as result of extensive complex protein chemical modifications. 
These proteins may be changed to proteins which are more sensitive to intracellular 
proteolysis (Davies, 1987) and are very quickly degraded by endogenous proteases 
(Stadtman & Bertlet, 1997). Protein oxidation by reactive oxygen species may lead to 
oxidation of side chains of amino acids residues and proteins can contain new functional 
groups (hydroxyl and carbonyl groups) (Fu et al., 1998), to cleavage of peptide bounds, to 
form new protein-protein cross bounds (Stadtman & Berlett, 1997). These changes can 
result in secondary modifications such as protein fragmentation, aggregation, unfolding 
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(Davies, 1987) whereby these processes are connected with change or loss protein activity 
and protein function (Stadtman, 1993). Children with bronchial asthma had higher level of 
protein carbonyls compared to the healthy children (Szlagatys-Sidorkiewicz et al., 2005). 
There was observed a trend for higher concentrations in protein carbonyls in atopic 
asthmatic children compared with control subjects (Schock et al., 2003). Increased level of 
protein carbonyls was observed also in BAL of atopic asthmatic children (Foreman et al., 
1999). We observed plasma protein modification in our group of asthmatic children 
(Babusikova et al., 2009). The total concentration of sulfhydryl groups was decreased 
during asthma. The value was lower in asthmatic group of children compared to the healthy 
subjects. Asthmatic patients with atopy had significantly lower amount of sulfhydryl groups 
than non-atopic patients. Nadeem et al. (2005) observed significant different in total 
sulfhydryl groups content between acute and stable asthmatics. Buss et al. (2003) observed 
3-chlorotyrosine in tracheal aspirate in significantly higher amounts in preterm infants with 
respiratory distress than in control infants. Nitrotyrosine was increased in exhaled breath 
condensate in patients with mild asthma (Hanazawa et al., 2000), in children (Baraldi et al., 
2006) and in airway epithelial lining fluid of asthmatic children (Fitzpatrick et al. 2009). 
In asthmatic children was observed increased level of eosinophils and mast cells compared 
to the healthy children (Schock et al., 2003). Several studies observed an increased level of 
eosinophils in adults with bronchial asthma in peripheral blood, in tissues and in exhaled 
breath condensate (Venge, 1995; 2010). In asthmatic children, the number of inflammatory 
cells in BAL fluid correlated significantly with the concentration of protein carbonyls 
(Schock et al., 2003). Increased respiratory burst can reflect increased oxidative stress, 
phagocyte auto-oxidation and subsequent intracellular oxidant release leading to additional 
inflammatory and lung damage in asthmatic children. Tissue damage and phagocyte 
activation can contribute to increased reactive oxygen species production. Activated 
phagocyte, neutrophils, eosinophils, monocytes and macrophage generate large amount of 
superoxide anion radical. 
3.1.2 Lipid peroxidation 
Lipid peroxidation is example of oxidative damage of biological membranes, lipoproteins 
and another lipid containing structures. It can be a very destructive process in a living 
system. Damaged biological membranes have changed biophysical properties. Proteins and 
lipids have limited mobility in membrane and membrane fluidity is decreased (Kaplan et al., 
2003). Peroxidation of membrane lipids leads to the production of isoprostanes. 
Isoprostanes are chemical stable substances and they can contribute to the 
pathophysiological changes seen in asthma. They are generated in vivo and are specific for 
lipid peroxidation (Praticò et al., 2001). Increased level of 8-isoprostanes was observed in 
exhaled breath condensate (Baraldi et al., 2003; Caballero Balanza et al., 2010; Montuschi et 
al., 1999), in plasma (Wood et al., 2000), as well as in urine and BAL (Dworski et al., 1999) of 
asthmatic patients. Ethane can reflect changes that are happened in consequence of lipid 
peroxidation (Kneepkens et al., 1994). Increased level of ethane which is produced following 
lipid peroxidation in exhaled breath was observed in adult with bronchial asthma (Paredi et 
al., 2000). Other markers of lipid peroxidation are thiobarbituric acid-reactive substances 
(TBARS) measuring the concentration of malondialdehyde, an end product of the oxidation 
of polyunsaturated fatty acids. Oxidative stress can cause accumulation of TBARS. We 
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observed increased levels of hiobarbituric acid-reactive substances in asthmatic children 
(Babusikova et al., 2009). Concentration of TBARS was significantly higher in exacerbated 
asthmatic children compared to controlled asthmatics and in atopic children levels of 
thiobarbituric acid-reactive substances enhanced compared to non-atopic as well. Increased 
level of TBARS was observed also in exhaled breath of asthmatic patients (Antczak et al., 
1997) and in plasma of asthmatic patients (Shanmugasundarasn et al., 2001). Concentration 
of malondialdehyde was higher in exhaled breath condensate in asthmatic children (Corradi 
et al., 2003, Kalayci et al., 2000). Increased level of malondialdehyde was observed also in 
BAL and peripheral blood sample of adult patients (Ozaras R et al., 2000). 
3.1.3 Antioxidant changes 
Antioxidant deficiencies have been frequently reported in patients with BA. The data are 
inconsistent, possibly due to variation in disease severity, diet, and ethnic, using techniques 
and using human fluids for measurement. Activities of enzymatic antioxidants have been 
reported increased, decreased, and unchanged as well. In children with asthma was 
observed increased activity of superoxide dismutase in erythrocytes and serum (Liao et al., 
2004; Szlagatys-Sidorkiewicz et al., 2005). Decreased and unchanged levels of antioxidant 
enzymes such as superoxide dismutase, catalase and glutathione peroxidase were observed 
(Comhair et al., 2000; Novak et al., 1991; Powell et al., 1994; Shanmugasundarasn et al., 
2001). Decreased activity of salivary peroxidase was found in children (Bentur et al., 2006). 
Total antioxidant capacity in serum of asthmatic children was decreased (Liao et al., 2004). 
Asthmatic patients with severe exacerbation of their disease have decreased serum total 
antioxidant status (Katsoulis et al., 2003). Concentration of glutathione peroxidase was not 
changed in asthmatic children (Marcal et al., 2004). Glutathione transferase shared catalytic 
properties for reaction of glutathione with reactive substrates. GST enzyme family is critical 
for protecting cells from reactive oxygen species because enzymes can utilize a wide range 
of products of oxidative damage as substrates. Members of glutathione transferase 
superfamily play an important role in the lungs during various physiological and 
pathophysiological conditions (Gilliland et al., 2002a, b, c). Peripheral blood lymphocyte 
glutathione concentration may potentially serve as a convenient marker of lung 
inflammation. The increase demand for glutathione production in the face of ongoing 
inflammation suggests a potential role for supplementation with cysteine donors (Lands et 
al., 1999). GSTM1 can be an important susceptibility factor for children with bronchial 
asthma after exposure during the fetal period (Gilliland et al., 2002a). Polymorphism within 
GSTP1 does not represent a major genetic factor in the development of bronchial asthma in 
children (Nickel et al., 2005). Variants of glutathione transferase confer risk to the 
development of asthma when the children are exposed to smoke (Kabesh et al., 2004). A 
significant decreased level of ǂ-tocopherol, ǃ-carotene, and ascorbic acid was detected in 
serum and erythrocytes of asthmatic children (Shanmugasundarasn et al., 2001; Kalayci et 
al., 2000). Composition of diet can also contribute to the increased development of bronchial 
asthma. Pulmonary functions are affected by intake of fresh fruit. Low intake of fruit rich in 
vitamin C is associated with an increased frequency of wheezing symptoms in children. 
Lung function parameters were lower in children with inadequate antioxidant vitamin 
intake (Gilliland et al., 2003). Decreased concentration of vitamins can suggest imbalance 
between antioxidant/oxidant status and it can be related with chronic airflow limitation. 
Diets and oxidative stress play a role in adults (Ochs-Balcom et al., 2006). Changes in 
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antioxidant-oxidant balance in BAL fluid in children with asthma may be an indicator of 
ongoing inflammatory event in symptom-free periods. This inflammation is associated with 
the increased production of reactive oxygen species or oxidative stress in lung. 
Individual parameters of oxidative damage influence reciprocally and together participate 
in the development of bronchial asthma (fig. 6). Estimation of all kind of markers of 
oxidative damage (proteins, lipids, DNA), together with estimation of antioxidant defence 
status, production of reactive oxygen species and genotype of relevant genes in the same 
time in asthmatic patients can be helpful for the selection the best treatment. 
 
Fig. 6. Participation of oxidative damage factors in origin of bronchial asthma. Oxidative 
damage results from polymorphism of antioxidant genes (influencing enzyme activity), 
activation of antioxidant pathways, and polymorphism of prooxidant genes and production 
of reactive oxygen species (influencing increased oxidative damage). 
3.1.4 Genetic changes in bronchial asthma related to oxidative damage 
Environmental and genetic factors play a role in the development of asthma; however, the 
exact mechanisms of these factors are not fully determined. A prominent aim of BA research 
is to understand the genetic and environmental triggers for bronchial asthma. Asthma 
clusters in families and twin studies suggest a strong genetic component to bronchial 
asthma. Having a parent with asthma doubles a child's risk of asthma, and having two 
affected parents increases the risk 4-fold (Gilliland et al., 2001). Many genes as well as gene-
gene interactions are associated with asthma (fig. 7). 
Superoxide dismutase represents the most important part of an active antioxidant defence. 
Since superoxide dismutase is decreased in asthma, and its activity is strongly related to BA 
pathophysiology, it has been hypothesized that genetic variations in superoxide dismutase 
may play a role in the development of asthma. The genes encoding SOD1, SOD2, SOD3 are 
located in different chromosomes and in all of them polymorphisms have been described. 
SOD1 is encoded on 21q22.1, SOD2 on 6q25.3, and SOD3 on 4p16.3-q21. Regulation of SOD 
genes plays a crucial role in balancing the reactive oxygen species concentration. In SOD1 
has been observed substitution of A to C at the non-coding position 35. This polymorphism 
influence SOD1 activity (Flekac et al., 2008). Substitution T to C at position 24, resulting in a 
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valine to alanine substitution at amino acid 16 has been identified in SOD2. Impairment of 
the mitochondrial superoxide dismutase activity was related to bronchial asthma 
pathophysiology (Comhair et al., 2005). In SOD3 gene has been identified three single 
nucleotide polymorphism: alanine to threonine substitution at amino acid 40, phenylalanine 
to cysteine at amino acid 131, and finally the most studied polymorphism which represents 
substitution of arginine to glycine at amino acid 213. Studies about superoxide dismutase 
polymorphisms are very rare in asthmatic population. In Chinese and Finnish asthmatic 
patients was not found significant differences either in allele or in genotype in SOD2 
(Kinnula et al., 2004; Mak et al., 2006). 
 
Fig. 7. Impact of genetic and environmental factors on bronchial asthma development. 
Catalase is a common antioxidant enzyme responsible for controlling hydrogen peroxide 
concentrations in cells. The catalase gene is located on chromosome 11p13. There are known 
different polymorphisms of this enzyme in coding regions (Goth, 1998; Kishimoto et al., 
1992) and in non-coding regions as well (Casp et al., 2002; Forsberg et al., 2001; Goth et al., 
2005; Kishimoto et al., 1992; Ukkola et al., 2001; Zhou et al., 2005; Wen et al., 1990). A 
common polymorphism in the promoter region of the catalase gene consists of a C to T 
substitution at position -262 in the 5' region (Forsberg et al., 2001), which is thought to result 
in reduced activity. CAT polymorphism may be associated with increased risk of asthma 
(Mak et al., 2006; Polonikov et al., 2009). In our study the frequency of TT genotype of 
catalase -262C→T was 0.226 in asthmatic children and 0.048 in healthy children (p < 0.001) 
and CAT polymorphism may be associated with increased oxidative damage in asthmatic 
subjects (unpublished results). 
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Glutathione transferase genes have been suggested as candidate genes for BA because they 
are involved in antioxidant defence pathways and they are expressed in the lungs. 
Glutathione transferases have historically also been called glutathione-S-transferases, and it 
is this latter name that gives rise to the widely used abbrevation, GST. Three major families 
of proteins the cytosolic, mitochondrial and microsomal (membrane-associated proteins in 
eicosanoids and glutathione metabolism, MAPEG) are known. In some organisms 
expression of GSTs are upregulated by exposure to prooxidants (An & Blackwell, 2003; 
Desikan et al., 2001; Veal et al., 2002). Seven classes of cytosolic glutathione transferases are 
recognising in mammals (Alpha, Mu, Pi, Sigma, Theta, Omega, and Zeta) (Hayes & Pulford, 
1995). At least 16 cytosolic GST subunits exists in human and display polymorphisms, and 
this is probably contributing factor to interindividual differences in responses to diseases 
and xenobiotics. GSTM1 is one of the genes encoding the Mu class of enzymes. Gene for 
GSTM1 has been mapped to glutathione transferase mu gene cluster on chromosome 1p13.3. 
Three polymorphisms of GSTM1 have been identified: a substitution (GSTM1A and 
GSTM1B) and a deletion (Rebbeck, 1997; Xu et al., 1998). The alleles of the substitution 
variant differ by C to G transition at base position 534, resulting in a lysine to asparagine 
substitution at amino acid 172 (Cotton et al., 2000; Rebbeck, 1997). There is no evidence to 
date that GSTM1A and GSTM1B alleles are functionally different from one another; thus 
these alleles are typically categorized together as a single functional phenotype. Other 
polymorphism is a deletion – GSTM1 null variant that results in a lack of functional gene 
product. The GSTT1 gene is located at 22q11.2. Absence of both alleles for this gene 
represents null variant analogous to GSTM1. Deletion of whole gene results in the lack of 
enzymatic activity (Sprenger et al., 2000). Gene for GSTP1 is one of the most intensive 
studying genes of glutathione transferase family and has been mapped on chromosome 
11q13 and comprising nine exons. There are known two polymorphisms of GSTP1: 
substitution of isoleucine to valine at amino acid 105 and alanine to valine at amino acid 114, 
demonstrating different catalytic efficiencies due to changes in the active site (Ali-Osman et 
al., 1997). A number of studies suggest that GSTM1, GSTT1, GSTM1 polymorphisms 
increase susceptibility to asthma (Babusikova et al., 2009; Hanene et al., 2007; Kamada et al., 
2007; Romieu et al., 2006; Tamer et al., 2004). GSTM1 and GSTT1 deficiency may increase the 
risk for the asthma development of in utero and current smoke exposure (Kabesch et al., 
2004). People with a GSTM1 null variant or GSTP1 Val/Val genotype show decreased in 
lung function growth (Gilliland et al., 2002b; Imboden et al., 2007). 
Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase (NQO1, 
EC 1.6.5.2) is phase II enzyme important in response to oxidative stress. NQO1 is highly 
expressed in the lungs. The gene for this protein is localised on chromosome 16q22.1. NQO1 
catalyzes the two-electron reduction of quinones to hydroquinones, thus bypassing the 
potentially toxic semiquinone radical intermediate (Jaiswal, 2000; Vasiliou et al., 2006) and 
prevents the generation of reactive oxygen species, and protects cells from oxidative 
damage. Some evidence suggest that NQO1 may also interact directly with reactive oxygen 
species (Jia et al., 2008), such as hydroxyl radical and hydrogen peroxide, and may influence 
the balance between oxidants and antioxidants. This enzyme can act also as an antioxidant 
enzyme by reducing ubiquinone (coenzyme Q10) and vitamin E quinone to their antioxidant 
forms (Beyer et al., 1996; Siegel et al., 1997) and bases on its influence on antioxidant 
mechanisms NQO1 is a candidate gene. Currently, there are 22 reported single-nucleotide 
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polymorphisms in the NQO1 gene. Only two of these, arginine139tryptophan and 
proline187serine (Larson et al., 1999; Traver et al., 1992) have been studied extensively. The 
NQO1 gene plays an important role in asthma susceptibility (David et al., 2003; Li et al., 
2009). Functional polymorphism of NQO1 gene with conjugation of GSTM1 null variant can 
have a protective effect in relation to asthma risk (David et al., 2003). For individuals already 
exhibiting disease status, a decrease or loss of NQO1 activity due to mutation, can play a 
role by increasing the risk of severity (Goodrich et al., 2009). Polymorphism in NQO1 gene 
may be an important factor determining the intensity of medical therapy in asthmatic 
children. Asthmatic children with functional polymorphism of NQO1 may require more 
intensive pharmaceutical treatment to effectively control their asthma (Goodrich et al., 
2009). 
Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase, EC 1.6.3.1) is a 
membrane-associated enzyme that catalyzes the production of superoxide anion. This 
enzyme is one of the main sources of superoxide anion and is highly expressed in 
neutrophils and endothelial cells (Azumi et al., 1999). NADPH oxidase is multicomponent 
enzyme made up from six subunits: Rho guanosine triphosphatase and five subunits of 
phagocytic oxidases (phox). Gp91phox and gp22phox are transmembrane subunits, and 
p40phox, p47phox and p67phox are cytosol subunits. The gp22phox is also called 
cytochrome b ǂ subunit (CYBA) and presence of this protein in the NADPH oxidase 
determines the enzyme activity and production of superoxide radical (De Keluelanear et al., 
1999). There were identified three polymorphisms in gene for gp22phox subunit at position 
+242 in exon 4, which consists of a C to T substitution resulting in a histidine to tyrosine 
substitution at amino acid 72; in the 3' untranslated region at position 640 A is substituted 
by G, and the third polymorphism is located in the promoter region at position -930, which 
consists of a A to G substitution (Dinauer et al., 1990; Moreno et al., 2003). Polymorphism of 
CYBA can be an important genetic component that determines susceptibility to allergic form 
of BA (Ivanov et al., 2008). 
3.1.5 Antioxidant treatment 
Antioxidant therapy may be a useful treatment for bronchial asthma because oxidative 
damage is increased in asthmatic patients. Epidemiological studies suggest that antioxidant 
have a significant effect on the incidence and severity of BA (Fogarty & Britton, 2000; Smith 
et al., 1999). There are several antioxidants, including endogenous metobolites (glutathione, 
N-actylcysteine, heme oxygenase 1, uric acid), natural antioxidants and other nutrients 
(vitamins C and E, ǃ-carotene, co-enzyme Q10, urate, curcumin, ǂ lipoic acid, fish oil), and 
herbal molecules and polyphenols (esculitin, sulforaphane, resveratrol, caffeic acid 
phenethyl ester). Vitamin C and E are powerful antioxidants found in the lungs. Vitamin C 
is hydrophilic antioxidant and acts to quench radicals within cells and regenerates vitamin 
E. Vitamin E is a lipophilic chain-breaking antioxidant that acts by stopping the chain 
reaction involved in lipid peroxidation. Urate is hydrophilic and has chain-breaking 
properties and stabilizes vitamin C as well. Several authors observed decreased oxidative 
damage in asthmatic mice treated with antioxidants (Dittrich et al., 2009; Lee et al., 2009; 
Okamoto et al., 2006). Studies of antioxidant intake have provided conflicting results in 
asthmatic patients. Epidemiological studies indicate that elevated dietary intake of vitamin 
C may be associated with a reduced risk of asthma (Hatch, 1995; Soutar et al., 1997). On the 
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other hand, many studies do not indicate any relation between asthma and vitamin C 
(Fogarty et al., 2003; Troisi et al., 1995). Pearson et al. (2004) observed no benefit of dietary 
supplementation with vitamin E in adults with mild to moderate asthma. Controlled studies 
in humans, on both healthy subjects (Chatham et al., 1987; Samet et al., 2001) and 
individuals with asthma (Trenga et al., 2001), have also suggested that antioxidant 
supplementation (vitamin C and vitamin E) may protect against the acute effects of ozone 
on lung functioning. Supplementation with antioxidants might modulate the impact of 
ozone exposure on the small airways of children with moderate to severe asthma (Romieu et 
al., 2002). Vitamin A supplementation early in life was not associated with a decreased risk 
of asthma in an area with chronic vitamin A deficiency (Checkley et al., 2011). Diet 
supplementation with omega-3 fatty acids, Zn and vitamin C significantly improved asthma 
control test, pulmonary function tests and pulmonary inflammatory markers in children 
with moderately persistent bronchial asthma either singly or in combination (Biltagi et al., 
2009). Dietary supplementation with vitamins E and C benefits asthmatic adults who are 
exposed to air pollutants (Trenga et al., 2001). 
4. Conclusion 
Prevalence of bronchial asthma increases and represents very serious medical problems. 
Bronchial asthma is a complex multifactorial disease in which environmental factors, 
oxidative damage and genetic factors are responsible for initiating and modulating the 
progression of the disease. Several markers of oxidative damage in plasma, serum, exhaled 
breath, and as well as in bronchoalveolar lavage fluid are rising in patients with asthma. 
Oxidative damage represents an important factor contributing to the origin and persistence 
of airway inflammation in asthmatic subjects. The role of mentioned gene polymorphisms 
and many others gene polymorphisms as risk factors for the occurrence of bronchial asthma 
is still controversial. We still need new studies for clear determination gene polymorphisms 
which are related to asthma. Moreover multiple genotype analyses are necessary as well 
because a single gene polymorphism can be without relationship to increased risk of asthma 
but the combination of gene polymorphisms may have a significant effect for asthma 
development. Oxidative damage plays a significant role in the pathology of bronchial 
asthma therefore this process may represent a potential target of the therapy in asthmatic 
patients. In summary bronchial asthma is a no single disease; it is an umbrella of diseases 
associated with increased oxidative stress followed by an accumulation of oxidative 
damage. 
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